DUCHEMBIO

duchembio-logo

Dyukem Bio Medical imaging scan (positron emission tomography, one person: PET) prescription drugs is a radiopharmaceutical used in a company to manufacture the meantime, nuclear medicine (Nuclear Medicine) income sales and co-operation of the relevant medical equipment, as well as radiopharmaceutical manufacturing By expanding the scope of supply and supply, we are now establishing a foundation as a comprehensive medical service company and will contribute to medical development.

#People #Website #More

DUCHEMBIO

Industry:
Health Care Pharmaceutical

Founded:
2002-01-01

Address:
Seoul, Seoul-t'ukpyolsi, South Korea

Country:
South Korea

Website Url:
http://www.duchembio.com

Status:
Active

Contact:
02-332-4868

Technology used in webpage:
SPF Nginx Google Apps For Business DigiCert SSL RapidSSL Korea Telecom Cafe24 DNS LINE WORKS


Current Employees Featured

not_available_image

Kim Jong-woo
Kim Jong-woo CEO @ DuChemBio
CEO

Official Site Inspections

http://www.duchembio.com

  • Host name: 183.111.199.231
  • IP address: 183.111.199.231
  • Location: South Korea
  • Latitude: 37.5112
  • Longitude: 126.9741
  • Timezone: Asia/Seoul

Loading ...

More informations about "DuChemBio"

๋“€์ผ๋ฐ”์ด์˜ค

์ œ์กฐ๊ธฐ์ˆ  ๊ธฐ๋ฐ˜์˜ ์ฐจ์„ธ๋Œ€ ์•” ์ง„๋‹จ ๋ฐ ์น˜๋ฃŒ ๋ฐฉ์‚ฌ์„ฑ์˜์•ฝํ’ˆ ๊ฐœ๋ฐœ ๊ธฐ์—… (์ฃผ)๋“€์ผ๋ฐ”์ด์˜คSee details»

DuChemBio | Company Profile - ๋“€์ผ๋ฐ”์ด์˜ค

Greetings from DuChemBio CEO. The passion to challenge a new market where everything is a beginning! With our experience in Korea, we will pursue the passion in Southeast Asia. Go to Greetings from the CEO. Address 6,7F, 81, โ€ฆSee details»

DuChemBio - Crunchbase Company Profile & Funding

Where is DuChemBio 's headquarters? DuChemBio is located in Seoul, Seoul-t'ukpyolsi, South Korea. Who invested in DuChemBio? DuChemBio is funded by Company K Partners. When โ€ฆSee details»

Korea's No. 1 Radiopharmaceutical Company Innovation-driven ...

Duchembio, Co., Ltd. l Provider of next-generation diagnostic and therapeutic radiopharmaceuticals New Duchembio Overview 7 Company Name Duchembio Co., Ltd. CEO โ€ฆSee details»

Duchembio Co., Ltd. - LinkedIn

Duchembio Co., Ltd. Pharmaceutical Manufacturing Seoul, NA 134 followers No. 1 Radiopharmaceutical company in Korea with cutting-edge technologySee details»

DuChemBio Co., Ltd. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for DuChemBio Co., Ltd. of Daegu, Daegu. Get the latest business insights from Dun & Bradstreet.See details»

DuChemBio | Financial Information

Item: 2021: 2022: 2023: 1st Half of 2024: Amount Amount Amount Amount; Total assets: 59,986: 51,351: 49,277: 49,606: Total liabilities: 40,058: 33,757: 27,482: 25,356 ...See details»

DuChemBio - Products, Competitors, Financials, Employees, โ€ฆ

According to the Korea Biotechnology Industry Organization (KoreaBIO), over 60 radiopharmaceuticals have received U.S. FDA approval, including 13 cancer treatments that โ€ฆSee details»

DuChemBio - Contacts, Employees, Board Members, Advisors

Organization. DuChemBio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. DuChemBio has โ€ฆSee details»

DuChemBio Co., Ltd. - CMOCRO - Domain Name

The company is dedicated to the development, supply and commercialization of PET radio-pharmaceutical technology and tracers. DuChemBio develops and markets PET solutions that โ€ฆSee details»

DuChemBio - Overview, News & Similar companies | ZoomInfo.com

Who is DuChemBio. Established in 2002, DuChemBio is the largest radiopharmaceutical firm and the undisputed leader in the field of oncology and neurology PET imaging tracers in South โ€ฆSee details»

DuChemBio | Financial Information

DuChemBio has completed its own peculiar business scheme. It is expected to realize high profit from 2025. โ€ป Launching schedules for new drugs. 68 Ga-PSMA-11. First half of 2023; FES. โ€ฆSee details»

๊ธฐ์—…์†Œ๊ฐœ - ๋“€์ผ๋ฐ”์ด์˜ค

์ฐจ์„ธ๋Œ€ ์•” ์ง„๋‹จ๊ณผ ์น˜๋ฃŒ์šฉ ๋ฐฉ์‚ฌ์„ฑ์˜์•ฝํ’ˆ ์‹ ์•ฝ๊ฐœ๋ฐœ ์ „๋ฌธ๊ธฐ์—… ใˆœ๋“€์ผ๋ฐ”์ด์˜ค๋Š” ์•” ์ง„๋‹จ ๋ฐ ์น˜๋ฃŒ๋ฅผ ์œ„ํ•œ ๋ฐฉ์‚ฌ์„ฑ์˜์•ฝํ’ˆ ์‹ ์•ฝ ๊ฐœ๋ฐœ ์ „๋ฌธ๊ธฐ์—…์œผ๋กœ์„œ, ์‚ฐ์—…์˜ ๊ฐ€์žฅ ํ•ต์‹ฌ์š”์†Œ์ธ ์ œ์กฐ๊ธฐ์ˆ  ๊ฐœ๋ฐœ์— ์—ญ์ ์„ ๋‘๊ณ  โ€ฆSee details»

DuChemBio | History - ๋“€์ผ๋ฐ”์ด์˜ค

DuChemBio Co.,LTD.-DuChemBio Research Institute small-scale merger: 11. Launched FACBC (18F-Fluciclovine), 1st PET diagnostic agent for recurrent prostate cancer: 09. National โ€ฆSee details»

ImaginAb and DuChemBio Announce Manufacturing and โ€ฆ

Jun 16, 2022 About DuChemBio Established in 2002, DuChemBio is the largest radiopharmaceutical firm and the undisputed leader in the field of oncology and neurology PET โ€ฆSee details»

Organization: Duchembio - Cbonds.com

Organization: Duchembio Organization name. Duchembio Co Ltd. Country name. Republic of Korea Country of registration- Industry. Miscellaneous Healthcare: Products and Services. โ€ฆSee details»

DuChemBio Co. Ltd., advised by BGM, has signed an ... - BGM โ€ฆ

News about our organization and our activities DuChemBio Co. Ltd., advised by BGM, has signed an Exclusive Development and Licensing Agreement with Yantai Dongcheng Pharmaceutical โ€ฆSee details»

Duchembio files for IPO to grow radiopharma business

Nov 11, 2024 Radiopharmaceutical biotech and contract development and organization firm Duchembio Co. Ltd. filed a securities report to South Koreaโ€™s Financial Services Commission โ€ฆSee details»

DuChemBio | Greetings from CEO - ๋“€์ผ๋ฐ”์ด์˜ค

DuChemBio. โ€œCeaselessly Securing Manufacturing Technologiesโ€ The Radiopharmaceutical industry is clearly distinguished from other pharmaceutical businesses, particularly in terms of โ€ฆSee details»